159 related articles for article (PubMed ID: 19048252)
1. Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.
Mine T; Matsueda S; Li Y; Tokumitsu H; Gao H; Danes C; Wong KK; Wang X; Ferrone S; Ioannides CG
Cancer Immunol Immunother; 2009 Aug; 58(8):1185-94. PubMed ID: 19048252
[TBL] [Abstract][Full Text] [Related]
2. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.
Wright MH; Calcagno AM; Salcido CD; Carlson MD; Ambudkar SV; Varticovski L
Breast Cancer Res; 2008; 10(1):R10. PubMed ID: 18241344
[TBL] [Abstract][Full Text] [Related]
3. Are CD44
Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin.
Alshaer W; Alqudah DA; Wehaibi S; Abuarqoub D; Zihlif M; Hatmal MM; Awidi A
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357721
[TBL] [Abstract][Full Text] [Related]
5. [Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship with Ovarian Cancer Stem Cell Markers CD117, CD133, ALDH1.].
Jing H; Liu XY; Chen YL; Bai LP; Zheng A
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):878-882. PubMed ID: 28598117
[TBL] [Abstract][Full Text] [Related]
6. NK Cells Lose Their Cytotoxicity Function against Cancer Stem Cell-Rich Radiotherapy-Resistant Breast Cancer Cell Populations.
Jin H; Kim HJ
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502547
[TBL] [Abstract][Full Text] [Related]
7. Association of CD44
Chekhun VF; Lukianova NY; Chekhun SV; Bezdieniezhnykh NO; Zadvorniy TV; Borikun TV; Polishchuk LZ; Klyusov OМ
Exp Oncol; 2017 Sep; 39(3):203-211. PubMed ID: 28967645
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
[TBL] [Abstract][Full Text] [Related]
9. STAT3 as a promising chemoresistance biomarker associated with the CD44
Moreira MP; da Conceição Braga L; Cassali GD; Silva LM
Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988
[TBL] [Abstract][Full Text] [Related]
10. Mammalian Numb protein antagonizes Notch by controlling postendocytic trafficking of the Notch ligand Delta-like 4.
Shao X; Ding Z; Zhao M; Liu K; Sun H; Chen J; Liu X; Zhang Y; Hong Y; Li H; Li H
J Biol Chem; 2017 Dec; 292(50):20628-20643. PubMed ID: 29042443
[TBL] [Abstract][Full Text] [Related]
11. iNOS promotes CD24
Wang R; Li Y; Tsung A; Huang H; Du Q; Yang M; Deng M; Xiong S; Wang X; Zhang L; Geller DA; Cheng B; Billiar TR
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10127-E10136. PubMed ID: 30297396
[TBL] [Abstract][Full Text] [Related]
12. Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8
Chen HC; Joalland N; Bridgeman JS; Alchami FS; Jarry U; Khan MWA; Piggott L; Shanneik Y; Li J; Herold MJ; Herrmann T; Price DA; Gallimore AM; Clarkson RW; Scotet E; Moser B; Eberl M
Immunol Cell Biol; 2017 Aug; 95(7):620-629. PubMed ID: 28356569
[TBL] [Abstract][Full Text] [Related]
13. High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance.
Ryoo IG; Choi BH; Ku SK; Kwak MK
Redox Biol; 2018 Jul; 17():246-258. PubMed ID: 29729523
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma.
Han SA; Jang JH; Won KY; Lim SJ; Song JY
Pathol Res Pract; 2017 Aug; 213(8):956-963. PubMed ID: 28687160
[TBL] [Abstract][Full Text] [Related]
15. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of Notch1 signaling suppresses properties of lung cancer stem cells.
Cai H; Lu W; Zhang Y; Liu H; Wang Z; Shen Y
J Cancer Res Ther; 2019; 15(7):1547-1552. PubMed ID: 31939436
[TBL] [Abstract][Full Text] [Related]
17. CD44
Hui D; Chen J; Jiang Y; Pan Y; Zhang Z; Dong M; Shao C
Exp Cell Res; 2020 May; 390(2):111968. PubMed ID: 32197932
[TBL] [Abstract][Full Text] [Related]
18. High GD2 expression defines breast cancer cells with enhanced invasiveness.
Mansoori M; Roudi R; Abbasi A; Abolhasani M; Abdi Rad I; Shariftabrizi A; Madjd Z
Exp Mol Pathol; 2019 Aug; 109():25-35. PubMed ID: 31075227
[TBL] [Abstract][Full Text] [Related]
19. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
Calaf GM; Ponce-Cusi R; Abarca-Quinones J
Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of a novel Delta-like 1 functional unit as a tool for Notch pathway activation and generation of a specific antibody.
Ferreira A; Lamy M; Margarida Rocha M; Silva G; Bandeiras TM; Barbas A
Protein Expr Purif; 2018 Jun; 146():8-16. PubMed ID: 29366964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
